Disagree
Home Beligas Pharmaceuticals Beligas Pharmaceuticals
Retho-Cialis 5
Retho-Cialis 5 - Beligas Pharmaceuticals

Retho-Cialis 5 - Beligas Pharmaceuticals

Brand:
Category:
Substance:
Dosage:
5 mg/tab
Package:
100 tablets
Price:
0
See options
Product Overview
Tadalafil emerged as a clinically approved compound for treating erectile dysfunction, later expanding into use for lower urinary tract symptoms and pulmonary issues. Its unique profile includes a long half-life, giving users up to 36 hours of benefit from a single dose. Outside of medical use, bodybuilders began experimenting with it for its vasodilatory effects, aiming to improve blood flow, muscle fullness, and endurance. Unlike anabolic agents, Tadalafil works through cardiovascular channels, offering support without disrupting natural hormone balance.
References:

Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Retho-Cialis 5 by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.

Explore More Products
FAQ
Is Tadalafil only used for erectile function?
No, Tadalafil is also used to manage pulmonary hypertension and may support general cardiovascular performance.
References:

Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.

Can Tadalafil be used daily in low doses?
Yes, Tadalafil is available in daily formulations for continuous support rather than on-demand use.
References:

Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.

Does Tadalafil interact with nitric oxide pathways?
Tadalafil enhances the effect of nitric oxide, which helps relax vascular smooth muscle and improve blood flow.
References:

Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.